The bone wax market is witnessing growth due to the rising number of surgical procedures globally. Surgical interventions such as orthopedic surgeries, neurosurgery, and cardiothoracic surgeries often require the use of bone wax to control bleeding from bony surfaces, driving demand for bone wax products.
Due to the elderly growth of population world wide understand more age-related deficiencies need surgical procedures. The reasons for wide use bone wax in orthopedics are very obvious. It is an essential item lots of elderly people have osteoporosis and fractures that are treated by orthopedic operations such as fracture repair and joint replacement surgery.
Technological progress in the formulations creating bone wax and the manufacturing processes is increasingly contributing to the expansion of the market. Manufacturers are coming up with new bone wax products that have side crust, adjuvant properties, and ease of use in line with the needs of surgeons, and healthcare facilities for the treatment of surgical patients.
Bone wax is passing from the conventional to other medical disciplines as well with the help of newly introduced fields. Since, dentists, maxillofacial surgeons and plasticians have begun to include bone wax in their treatment that produces hemostasis and accelerates the healing of bone wound which then concordantly expands the market for bone wax products.
The bone wax market is witnessing consolidation through mergers, acquisitions, and strategic partnerships among key players. Companies are leveraging these collaborations to expand their product portfolios, enhance market presence, and capitalize on synergies to drive growth and innovation in the bone wax market.
Patient safety and clinical outcomes remain paramount in driving market trends in the bone wax market. Surgeons and healthcare facilities prioritize bone wax products that demonstrate efficacy in achieving hemostasis, promoting tissue healing, and minimizing the risk of complications, thereby enhancing patient safety and optimizing surgical outcomes.
The bone wax market has been segmented into product, material, application, and end-user.
The market, on the basis of product, is segmented into absorbable bone wax and non-absorbable bone wax.
The market, by material, has been segmented into natural bone wax and synthetic bone wax.
The market, by application, has been segmented into neurosurgery, orthopedic surgery, thoracic surgery, oral surgery, and others.
On the basis of end-user, the market has been segmented into hospitals, clinical laboratories, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The bone wax market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European bone wax market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The bone wax market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The bone wax market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players
ABYRX, Inc., Wound Management Technologies, Inc., Aesculap, Inc., Ethicon, Inc., Medtronic Plc, Baxter International, Medline Industries, Inc., Futura Surgicare Pvt. Ltd., CP Medical Corp., Bentley Healthcare Pvt. Ltd., WNDW Medical Inc., GPC Medical Ltd., and others are some prominent players in the bone wax market.
Geographically, the Americas is anticipated to dominate the bone wax market owing to a well-developed healthcare sector, rising number of surgeries, steady growing occurrence of orthopedic diseases, growing number of surgeries and relatively large number of research and development activities. According to an article published by the National Center for Biotechnology Information (NCBI) in 2016, osteoarthritis (OA) is affecting an estimated 12% of the US adults in the age group 25 to 74 years.
Europe is expected to hold the second largest position in the bone wax market. The market growth in this region is attributed to the rising prevalence of orthopedic disease, increasing occurrences of accidents and injuries, and increasing expenditure on the healthcare sector. According to the Eurostat, around 7.1 million in-patients with injuries, poisoning and other consequences such as accidents were discharged from hospitals in the European Union (EU) in 2015.
The bone wax market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the fastest growing region in the market due to continuously developing economies, rising prevalence of bone diseases, an increasing number of geriatric populations, and increasing government funding for the healthcare sector. According to the report by the United Nations Department of Economic and Social Affairs, in India, the number of older persons is projected to grow by 64% between the years 2015 and 2030. It also projected that the number of older persons in China is projected to grow by 71% over the same period.
On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector, and the growing prevalence of bone disorders and growing government initiatives for the healthcare sector.
Bone Wax Market, by Product
Bone Wax Market, by Material
Bone Wax Market, by Application
Bone Wax Market, by End-User
Bone Wax Market, by Region
Recent Development
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)